BioInnovation Institute welcomes twelve new companies to its Venture Lab program

is developing precision probiotics for PFAS detoxification.SNL Biosolutions has developed an innovative technology platform that can produce fermentation-based oils at scale and prevent deforestation. The technology can be used to produce a wide range of products spanning from food ingredients to sustainable aviation fuel.SymbioMATCH produces effective biofertilizers tailored to each soil condition and legume crop.

Therapeutics

PreTT is a pioneer in advancing pre-targeted radioimmunotherapies to improve the lives of millions of cancer patients.Polyceutix is transforming cancer treatment by unleashing the full power of the immune system exactly where it is needed.

Women's Health

Pharmista Technologies is developing a reusable pregnancy test which will be the start of a new generation of reusable diagnostics.oasicare is on a mission to improve women's health during childbirth and postpartum on a global scale. The Company's first solution is a medical device preventing the risk of birth tears.

Health Tech

Zeta Diagnostics is developing a portable audio device that allows physicians to detect middle ear problems before they become permanent complications.Glaze Life Sciences is developing a non-invasive device to measure blood glucose to improve the everyday life of people living with diabetes.

Quantum

DiaSense is developing a quantum diamond-magnetic microscope to be used by neuroscientists to diagnose diseases and find cures.Sqale is revolutionizing biomanufacturing by using quantum technologies.Alea Quantum Technologies has developed a quantum random number generator that will enable safe and trusted data sharing in the post-quantum era.

Since its inception in 2018, BII has supported 100 start-ups and projects with EUR 89 million alongside the venture capital, industry and business expertise it provides to help them accelerate to the next level.  In total, BII's start-ups have raised over EUR 428 million in external funding from both local and international investors.  Recent company successes include Embark Laboratories, Adcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.

Read more about the Venture Lab program 

About the BioInnovation Institute Foundation:

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per projects and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com 

View original content:https://www.prnewswire.co.uk/news-releases/bioinnovation-institute-welcomes-twelve-new-companies-to-its-venture-lab-program-302074565.html

@ prnewswire.co.uk

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.